By contrast, the list of tumor cell targets for Vδ1 or Vδ3 cells are narrow, but may be expanded in the future, and there is a concern regarding the pro-inflammatory nature of Vδ1 cells because of their propensity to express the cytokines IL-17 or IL-4. This evidence concerns the gene IL17A and neoplasm.